Showing results (1571-1580 of 1,886) with videos related to

Sort By:
Pageof 189
Therapeutic Advances in Neurological Disorders|December 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseasesMuriel Schraad, Mathias Mäurer, Anke Salmen, et al.
Cell|April 17, 2018
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 BlockadeSachet A Shukla, Pavan Bachireddy, Bastian Schilling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO GuidelineBianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, et al.
Genomics|January 14, 2024
A risk-reward examination of sample multiplexing reagents for single cell RNA-SeqDaniel V Brown, Casey J A Anttila, Ling Ling, et al.
Journal for Immunotherapy of Cancer|March 17, 2023
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Zoonoses and Public Health|December 15, 2017
Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAEC R Paden, M F B M Yusof, Z M Al Hammadi, et al.
JAMA Neurology|March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.
Lancet (London, England)|January 21, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S Weber, Matteo S Carlino, Adnan Khattak, et al.
Physical Review Letters|May 20, 2017
Transition from Collisional to Collisionless Regimes in Interpenetrating Plasma Flows on the National Ignition FacilityJ S Ross, D P Higginson, D Ryutov, et al.
Pageof 189